Загрузка...
Atypical immunologic response in a patient with CRIM-negative Pompe disease
We report the clinical course of a patient with severe infantile onset Pompe disease [cross-reactive immunologic material (CRIM) negative, R854X/R854X] who was diagnosed prenatally and received standard dosing of alglucosidase alfa (Myozyme®) enzyme replacement therapy (ERT) from day 10 of life unti...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3711241/ https://ncbi.nlm.nih.gov/pubmed/21889385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgme.2011.08.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|